(Yicai Global) Jan. 19 -- Chinese drugmaker Porton Fine Chemicals Ltd. has received the go-ahead from Japanese regulators to sell anti-malaria medicine in the country, as part of the firm's plans to expand its presence globally.

The Chongqing-based company received notification from Japan's Pharmaceuticals and Medical Devices Agency this week that it has passed on-site inspections, Porton said in a press briefing yesterday.

The evaluation of the firm's manufacturing facility covered product quality, production, equipment and facilities, laboratory control, materials, and package labeling.

Established in July 2005, Porton is a provider of customized pharmaceutical research, development and production services for multinational pharmaceutical companies and biopharmaceutical companies in accordance with international standards. The company has a technology research and development center in New Jersey, US, which delivers full life-cycle research, process development, and production services to the biopharmaceutical industry in the country.